Lupus kliniske forsøg i Michigan
10 studier for Lupus søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50219, Detroit
RekruttererFase 3
Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- AA MRC LLC - Grand Blanc, Grand Blanc
- June DO, PC, Lansing
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Henry Ford Health, Detroit
- Ahmed Arif Medical Research Center, Grand Blanc
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT06133972A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Revive Research Institute, Sterling Heights
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07438496A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Oakland Hills Dermatology, Auburn Hills
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Revival Research Institute, LLC, Troy
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07332481A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0034, Ann Arbor
- AA MRC, Grand Blanc
RekruttererObservationsstudie
Alder 16 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07175285A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Revive Research Institute, LLC, Sterling Heights
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 30. jul. 2026 · NCT07201129A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Flint
- Investigative Site, Troy
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 27. jul. 2026 · NCT07260877Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- University of Michigan, Ann Arbor
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 11. maj 2026 · NCT06208514Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.